Company
APT Medical, Inc.
Headquarters: Shenzhen, China
Employees: 1,511
Market Cap
CN¥34.70 Billion
CNY as of Jan. 1, 2025
US$4.75 Billion
APT Medical, Inc. Categories
China Healthcare Medical DevicesChina Healthcare China Medical Devices
Top Competitors by Market Capitalization
Industry: Medical Devices
| Company | Market Cap (USD) |
|---|---|
| Abbott | $213.72 B |
| Stryker | $150.01 B |
| Boston Scientific Corporation | $149.80 B |
| Medtronic | $114.44 B |
| Shenzhen Mindray Bio-Medical Electronics Co. Ltd | $47.37 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $689.42 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $487.54 B |
| Johnson & Johnson | $353.05 B |
| AbbVie | $301.60 B |
Detailed Description
APT Medical Inc. engages in the research and development, manufacture, and sale of invasive interventional medical devices for cardiovascular and cerebrovascular diseases worldwide. The company offers electrophysiological catheter delivery systems, as well as radiofrequency ablation and mapping catheters; and vascular intervention products, such as diagnostic and treatment products, and intervention accessories. It also provides OEM/ODM services to catheter and metal products, as well as accessories. The company was founded in 2002 and is headquartered in Shenzhen, China.
Top 1-year algo backtest: +327.04%
$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Financials
| Last Financial Reports Date | Sept. 30, 2024 |
| Revenue TTM | CN¥1.96 B |
| EBITDA | CN¥756.2 M |
| Gross Profit TTM | CN¥1.18 B |
| Profit Margin | 33.59% |
| Operating Margin | 40.29% |
| Quarterly Revenue Growth | 23.10% |
Stocks & Indices
APT Medical, Inc. has the following listings and related stock indices.
Stock: SSE: 688617 wb_incandescent